Fintel reports that on November 13, 2025, BMO Capital initiated coverage of Privia Health Group (NasdaqGS:PRVA) with a ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

Fintel reports that on November 13, 2025, JP Morgan maintained coverage of Privia Health Group (NasdaqGS:PRVA) with a ...

Investors in Privia Health Group Inc (Symbol: PRVA) saw new options become available this week, for the May 2026 expiration. One of the key inputs that goes into the price an option buyer is willing ...

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year ...

PRVA is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of PRVA shares has decreased $0.10 since the market last closed. This is a 0.41% ...

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care. Privia Health (NASDAQ: PRVA) came out with quarterly earnings of $0.03 ...

Detailed price information for Collegium Pharma (COLL-Q) from The Globe and Mail including charting and trades.